553 related articles for article (PubMed ID: 28688279)
21. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
22. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
23. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
24. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
25. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
27. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A
Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638
[TBL] [Abstract][Full Text] [Related]
28. New 3-
Loh ZH; Kwong HC; Lam KW; Teh SS; Ee GCL; Quah CK; Ho ASH; Mah SH
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):627-639. PubMed ID: 33557647
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of acridone glycosides as selective BChE inhibitors.
Ma W; Bi J; Zhao C; Gao Y; Zhang G
Carbohydr Res; 2020 May; 491():107977. PubMed ID: 32169593
[TBL] [Abstract][Full Text] [Related]
30. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP
Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788
[TBL] [Abstract][Full Text] [Related]
31. Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
Ghafary S; Najafi Z; Mohammadi-Khanaposhtani M; Nadri H; Edraki N; Ayashi N; Larijani B; Amini M; Mahdavi M
Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800115. PubMed ID: 30284339
[TBL] [Abstract][Full Text] [Related]
32. Cholinesterase inhibitory alkaloids from the rhizomes of Coptis chinensis.
Cao TQ; Ngo QT; Seong SH; Youn UJ; Kim JA; Kim J; Kim JC; Woo MH; Choi JS; Min BS
Bioorg Chem; 2018 Apr; 77():625-632. PubMed ID: 29502023
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological evaluation, and docking studies of some 5-chloro-2(3H)-benzoxazolone Mannich bases derivatives as cholinesterase inhibitors.
Uysal S; Parlar S; Tarikogullari AH; Aydin Kose F; Alptuzun V; Soyer Z
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700273. PubMed ID: 29527733
[TBL] [Abstract][Full Text] [Related]
34. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Saeed A; Zaib S; Ashraf S; Iftikhar J; Muddassar M; Zhang KY; Iqbal J
Bioorg Chem; 2015 Dec; 63():58-63. PubMed ID: 26440714
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors.
Nakayama K; Schwans JP; Sorin EJ; Tran T; Gonzalez J; Arteaga E; McCoy S; Alvarado W
Bioorg Med Chem; 2017 Jun; 25(12):3171-3181. PubMed ID: 28416102
[TBL] [Abstract][Full Text] [Related]
38. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
39. Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors.
Kumar RS; Almansour AI; Arumugam N; Al-Thamili DM; Basiri A; Kotresha D; Manohar TS; Venketesh S; Asad M; Asiri AM
Bioorg Chem; 2018 Dec; 81():134-143. PubMed ID: 30121001
[TBL] [Abstract][Full Text] [Related]
40. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J
Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]